Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJUS.L Regulatory News (JUS)

  • There is currently no data for JUS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Jupiter US Smaller Companies (JUS)

17 May 2018 14:03

RNS Number : 4649O
Jupiter US Smaller Companies PLC
17 May 2018
 

 

London, UK, 17 May 2018

Edison issues review on Jupiter US Smaller Companies (JUS)

Jupiter US Smaller Companies (JUS) aims to generate long-term capital growth from a focused portfolio of mid- and small-cap US equities. Since 2001, the trust has been managed by Robert Siddles. Following the announcement of adjustments to JUS's investment process - running a more concentrated portfolio, a greater focus on selling underperforming holdings, while holding on to successful positions for longer - the trust has enjoyed an improvement in investment performance. It has delivered above market results in periods of both positive and negative stock market returns, illustrating its commitment to capital preservation. The board has also reduced JUS's management fees, removed the performance fee and introduced the trust's first gearing facility.

 

JUS's current 8.0% share price discount to cum-income NAV is narrower than the

averages of the last one and three years of 9.0% and 10.3% respectively, but wider

than the 7.2% and 6.7% averages of the last five and 10 years. The board actively

repurchases shares, aiming to ensure that the discount does not exceed 8% (in

normal market conditions). There is scope for the discount to narrow if the manager

continues to build on his improved recent investment performance.

 

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEADSXFEEPEFF
Date   Source Headline
17th Mar 202110:21 amRNSNet Asset Value(s)
16th Mar 202111:11 amRNSInitiation research from QuotedData
16th Mar 20219:33 amRNSNet Asset Value(s)
15th Mar 202110:36 amRNSNet Asset Value(s)
12th Mar 202111:42 amRNSChange of Investment Manager
12th Mar 20219:39 amRNSNet Asset Value(s)
12th Mar 20217:00 amRNSHalf Year Results to 31 December 2020
11th Mar 20219:55 amRNSNet Asset Value(s)
10th Mar 20219:59 amRNSNet Asset Value(s)
9th Mar 20215:13 pmRNSTransaction in Own Shares
9th Mar 202110:26 amRNSNet Asset Value(s)
8th Mar 20215:19 pmRNSTransaction in Own Shares
8th Mar 20219:43 amRNSNet Asset Value(s)
5th Mar 20215:25 pmRNSTransaction in Own Shares
5th Mar 202110:11 amRNSNet Asset Value(s)
4th Mar 202110:43 amRNSNet Asset Value(s)
3rd Mar 202110:04 amRNSNet Asset Value(s)
2nd Mar 20219:47 amRNSNet Asset Value(s)
1st Mar 20215:27 pmRNSTransaction in Own Shares
1st Mar 202110:36 amRNSNet Asset Value(s)
26th Feb 20216:26 pmRNSTotal Voting Rights
26th Feb 20215:41 pmRNSTransaction in Own Shares
26th Feb 202111:16 amRNSNet Asset Value(s)
25th Feb 202110:16 amRNSNet Asset Value(s)
24th Feb 20215:22 pmRNSTransaction in Own Shares
24th Feb 202110:18 amRNSNet Asset Value(s)
23rd Feb 202110:33 amRNSNet Asset Value(s)
22nd Feb 202110:55 amRNSNet Asset Value(s)
19th Feb 20219:43 amRNSNet Asset Value(s)
18th Feb 20215:30 pmRNSTransaction in Own Shares
18th Feb 20219:46 amRNSNet Asset Value(s)
17th Feb 202111:04 amRNSNet Asset Value(s)
16th Feb 202110:22 amRNSNet Asset Value(s)
15th Feb 20215:20 pmRNSPortfolio Update
15th Feb 202110:13 amRNSNet Asset Value(s)
12th Feb 20215:23 pmRNSTransaction in Own Shares
12th Feb 202111:40 amRNSNet Asset Value(s)
11th Feb 20215:06 pmRNSTransaction in Own Shares
11th Feb 202110:13 amRNSNet Asset Value(s)
10th Feb 20215:10 pmRNSTransaction in Own Shares
10th Feb 202110:05 amRNSNet Asset Value(s)
9th Feb 20219:48 amRNSNet Asset Value(s)
8th Feb 20213:02 pmRNSHolding(s) in Company
8th Feb 202111:57 amRNSNet Asset Value(s)
5th Feb 20219:36 amRNSNet Asset Value(s)
4th Feb 20215:26 pmRNSTransaction in Own Shares
4th Feb 202110:45 amRNSNet Asset Value(s)
3rd Feb 20212:47 pmRNSBlock listing Interim Review
3rd Feb 20219:44 amRNSNet Asset Value(s)
2nd Feb 20215:27 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.